British Biotech’s Gene Therapy for Rare ‘Bubble Baby’ Disease gets Fast-Tracked by the FDA – Labiotech.eu (blog)
Labiotech.eu (blog) |
British Biotech’s Gene Therapy for Rare ‘Bubble Baby’ Disease gets Fast-Tracked by the FDA
Labiotech.eu (blog) Orchard Therapeutics has received rare pediatric disease designation for OTL-101, a gene therapy for the treatment of the rare disease ADA-SCID. Orchard Therapeutics, launched just a year ago in London, is developing what could be a new version of … |
International Business Times |
HIV Cure Hopes Revived After South African Kid’s Remission, Possible Immunotherapy Links
International Business Times However, a report BBC, published Monday discussed the possibilities of finding a permanent cure for HIV after it was found that a new branch of immunotherapy drugs known as “checkpoint inhibitors” allow the immune system to continue fighting, resulting … Hunt for HIV cure turns to cancer drugsBBC News Cancer Immunotherapy Might Help Find HIV TreatmentImmortal News In search of cure for HIVDunyaNews Pakistan Chronicle Day –Yahoo News UK –BBC News all 147 news articles » |
USA TODAY |
CRISPR gene editing tool: Are we ready to play God?
USA TODAY Humans had better be ready to play God. Because we’ve now got the tools to do just that. Credit the recent discovery of CRISPR-Cas9, a powerful gene-editing tool that gives scientists the ability to make precise edits of single strands of DNA. Other so … What is CRISPR-Cas9?Alphr Crispr Theraptc (CRSP) CEO Sells $166,380.25 in Stock – Sports …Sports Perspectives Kurt Von Emster Sells 81435 Shares of CRISPR THERAPTC (NASDAQ:CRSP) StockStock Observer Community Financial News –Chaffey Breeze –Breaking Finance News all 9 news articles » |
|
Companies rush to develop ‘utterly transformative’ gene therapies
Pharmacy Today, American Pharmacists Association, pharmacist.com Gene therapies to treat leukemia and lymphoma are on the brink of approval, driving industry and academic researchers into a frenzy to develop similar treatments for other types of cancers. The excitement is palpable, with Stephan Grupp, MD, of … |